Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.

Caglar K., Cetinkaya A., Aytac Ş. S., Gumruk F., Gurgey A.

Pediatric hematology and oncology, vol.20, no.6, pp.435-8, 2003 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 6
  • Publication Date: 2003
  • Doi Number: 10.1080/08880010390220135
  • Journal Name: Pediatric hematology and oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.435-8
  • Hacettepe University Affiliated: Yes

Abstract

Glanzmann thrombasthenia is a very rare inherited platelet function disorder in which bleeding may be extremely difficult to stop. Recombinant factor VIIa is one of the alternative treatments for bleeding. The authors report here their experience with the use of factor VIIa, which may be useful for arresting bleeding in Glazmann thrombasthenia.